Boston Scientific (BSX) Stock Forecast, Price & News

Boston Scientific (NYSE:BSX) Frequently Asked Questions

Is Boston Scientific a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Boston Scientific stock.
View analyst ratings for Boston Scientific or view top-rated stocks.

Are investors shorting Boston Scientific?

Boston Scientific saw a decrease in short interest in April. As of April 15th, there was short interest totaling 11,970,000 shares, a decrease of 23.6% from the March 31st total of 15,670,000 shares. Based on an average trading volume of 9,060,000 shares, the days-to-cover ratio is currently 1.3 days. Approximately 0.9% of the company's shares are short sold.
View Boston Scientific's Short Interest.

When is Boston Scientific's next earnings date?

Boston Scientific is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Boston Scientific.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) posted its earnings results on Wednesday, April, 27th. The medical equipment provider reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. The medical equipment provider earned $3.03 billion during the quarter, compared to analysts' expectations of $2.95 billion. Boston Scientific had a trailing twelve-month return on equity of 14.60% and a net margin of 6.65%. The company's revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 EPS.
View Boston Scientific's earnings history.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its FY22 earnings guidance on Wednesday, April, 27th. The company provided EPS guidance of $1.74-1.79 for the period, compared to the consensus EPS estimate of $1.77. The company issued revenue guidance of ~$12.72-12.96 billion, compared to the consensus revenue estimate of $12.84 billion.

What price target have analysts set for BSX?

10 Wall Street analysts have issued 12-month price objectives for Boston Scientific's shares. Their forecasts range from $42.74 to $52.00. On average, they anticipate Boston Scientific's stock price to reach $49.30 in the next year. This suggests a possible upside of 24.3% from the stock's current price.
View analysts' price targets for Boston Scientific or view top-rated stocks among Wall Street analysts.

Who are Boston Scientific's key executives?

Boston Scientific's management team includes the following people:

• Mr. Michael F. Mahoney, Chairman, Pres & CEO (Age 57, Pay $3.83M) (LinkedIn Profile)
• Mr. Daniel J. Brennan, Exec. VP & CFO (Age 56, Pay $1.4M) (LinkedIn Profile)
• Mr. Joseph M. Fitzgerald, Exec. VP & Pres of Cardiology (Age 58, Pay $1.57M)
• Mr. David A. Pierce, Exec. VP and Pres of MedSurg & Pres of Endoscopy (Age 58, Pay $1.22M) (LinkedIn Profile)
• Mr. Jeffrey B. Mirviss, Exec. VP & Pres of Peripheral Interventions (Age 56, Pay $1.21M) (LinkedIn Profile)
• Mr. Edward F. Mackey, Exec. VP of Global Operations (Age 59) (LinkedIn Profile)
• Mr. Jonathan R Monson, VP, Global Controller & Chief Accounting Officer (LinkedIn Profile)
• Ms. Jodi Euerle Eddy, Sr. VP and Chief Information & Digital Officer (Age 49) (LinkedIn Profile)
• Ms. Susan Vissers Lisa, VP of Investor Relations
• Mr. Vance R. Brown, Sr. VP, Gen. Counsel & Corp. Sec.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific CEO Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among Boston Scientific's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Boston Scientific's key competitors?

Some companies that are related to Boston Scientific include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD), Teleflex (TFX) and Abiomed (ABMD).
View all of BSX's competitors.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.93%), Primecap Management Co. CA (2.65%), Bollard Group LLC (1.86%), Bank of New York Mellon Corp (1.13%), Parnassus Investments LLC (1.10%) and Northern Trust Corp (0.97%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Scott Olson, Wendy Carruthers and William F Bruss.
View institutional ownership trends for Boston Scientific.

Which institutional investors are selling Boston Scientific stock?

BSX stock was sold by a variety of institutional investors in the last quarter, including Newport Trust Co, Russell Investments Group Ltd., Jupiter Asset Management Ltd., CI Investments Inc., JPMorgan Chase & Co., Sei Investments Co., Group One Trading L.P., and Taurus Asset Management LLC. Company insiders that have sold Boston Scientific company stock in the last year include Daniel J Brennan, David A Pierce, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Scott Olson, Wendy Carruthers, and William F Bruss.
View insider buying and selling activity for Boston Scientific or view top insider-selling stocks.

Which institutional investors are buying Boston Scientific stock?

BSX stock was acquired by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Bank of New York Mellon Corp, Vanguard Group Inc., DSM Capital Partners LLC, Assenagon Asset Management S.A., Canada Pension Plan Investment Board, Bellevue Group AG, and Bridgewater Associates LP.
View insider buying and selling activity for Boston Scientific or or view top insider-buying stocks.

How do I buy shares of Boston Scientific?

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $39.66.

How much money does Boston Scientific make?

Boston Scientific has a market capitalization of $56.70 billion and generates $11.89 billion in revenue each year. The medical equipment provider earns $1.04 billion in net income (profit) each year or $0.529990 on an earnings per share basis.

How many employees does Boston Scientific have?

Boston Scientific employs 41,000 workers across the globe.

Does Boston Scientific have any subsidiaries?

The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.

When was Boston Scientific founded?

Boston Scientific was founded in 1979.

What is Boston Scientific's official website?

The official website for Boston Scientific is www.bostonscientific.com.

How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at (508) 683-4000, via email at [email protected], or via fax at 508-683-5675.